HCPCS code P9046: Albumin 25% infusion billing guide

Key takeaways

HCPCS code P9046 describes infusion, albumin (human), 25%, billed per 20 ml unit under Medicare Part B.

One unit equals 20 ml administered, so a 100 ml infusion is reported as five units.

Medicare reimburses P9046 at ASP plus 6%, and CMS refreshes those rates every quarter.

P9046 covers albumin 25%, while P9045 covers albumin 5%, and coding the wrong concentration is a common denial trigger.

Practice management software like Pabau tracks billing units and pairs supporting ICD-10 codes before the claim goes out.

HCPCS code P9046 describes a single billable unit of albumin (human) at 25% concentration, delivered as an infusion. The official descriptor reads: Infusion, albumin (human), 25%, 20 ml. Each unit reported on a claim corresponds to exactly 20 ml of the 25% solution administered.

The P-series covers blood and blood products from P9010 through P9100. P9046 sits alongside codes for fresh frozen plasma, cryoprecipitate, and other albumin concentrations. Confirm the status of P9046 against the CMS HCPCS annual update file before submitting claims. Code status can change each January.

Clinical indications for albumin 25% infusion

Medical necessity is the single biggest audit risk for HCPCS code P9046 claims. Medicare and commercial payers require documented clinical justification before reimbursing albumin infusion. Without it, the claim fails on review even when the coding is technically correct.

Albumin 25% is a concentrated colloid solution. It is used when rapid volume expansion is needed without a large fluid load, or when serum albumin is critically low. According to FDA labeling for albumin 25% products, approved clinical indications include:

• Hypovolemia: Acute volume depletion, particularly when crystalloid therapy is insufficient or contraindicated
• Burns: Resuscitation and maintenance in severe burn injuries where protein losses are significant
• Hepatic failure and cirrhosis: Management of hypoalbuminemia in liver disease, including spontaneous bacterial peritonitis prophylaxis
• Nephrotic syndrome: Short-term correction of severe hypoalbuminemia when edema is resistant to diuretics
• Hypoproteinemia: Perioperative or post-surgical protein depletion requiring albumin replacement
• Paracentesis: Post-large-volume paracentesis albumin replacement to reduce circulatory dysfunction risk

Coverage for specific indications varies by Medicare Administrative Contractor (MAC) Local Coverage Determination (LCD) and by commercial payer policy. Off-label uses may not be covered. Confirm the covered indication list with the relevant MAC before assuming reimbursement for an albumin infusion.

P9046 fee schedule and Medicare reimbursement

Medicare Part B reimburses HCPCS code P9046 under the Average Sales Price (ASP) methodology at ASP plus 6%. The payment rate equals the manufacturer’s weighted average selling price, net of discounts, plus a 6% add-on. CMS updates ASP pricing quarterly, so any dollar figure published outside official CMS files is likely out of date.

To look up the current reimbursement rate, use the CMS Physician Fee Schedule lookup or download the quarterly ASP drug pricing file. Enter P9046 to retrieve the per-20-ml reimbursement for the applicable quarter. Practices that run this check inside software for billing teams can automate the lookup and flag underpayments at remittance.

Rates vary by place of service. Hospital outpatient settings may reimburse under the Outpatient Prospective Payment System (OPPS) rather than the Part B drug fee schedule. Always confirm which payment system applies before projecting revenue for an albumin infusion service line.

How to bill HCPCS P9046: Billing guidelines

Billing HCPCS code P9046 correctly requires three things:

• The right unit count for the volume administered
• A supported place of service
• A paired ICD-10 diagnosis code that establishes medical necessity

Getting any one of these wrong is the fastest path to a denial.

Unit calculation

Report one unit of P9046 for each 20 ml of albumin 25% administered. If a patient receives 100 ml, report 5 units. If they receive 60 ml, report 3 units. Partial units are not billable, so round down to the nearest whole 20 ml increment. This per-20-ml convention is set by CMS and applies regardless of package size. Vials typically come in 50 ml and 100 ml sizes.

Place of service

P9046 is billed in physician office (POS 11), infusion center (POS 22), and hospital outpatient (POS 19/22) settings. The payment rate may differ by POS. Practices that infuse outside a fixed site should confirm the applicable POS code with their MAC. Home infusion (POS 12) carries coverage rules that differ from facility-based administration.

Modifiers

Modifiers are rarely required for P9046 itself. The infusion administration code is typically a CPT code from the 96360-96379 range. It may require modifier JW for discarded drug, or modifier JZ when nothing is discarded. Document the amount administered and the amount wasted to support modifier usage on the administration code. Check with your MAC for the modifier rules that apply to your payer contracts and infusion setting.

Proper claim denial management starts at submission. Confirm the unit count, the place of service, and the ICD-10 pairing before the claim leaves the practice. Rework after a denial costs far more staff time than a pre-submission review.

ICD-10 diagnosis codes that support P9046

Every P9046 claim needs at least one ICD-10-CM diagnosis code that demonstrates the medical necessity of albumin infusion. The codes below are commonly paired with P9046, based on clinical indications recognized in FDA labeling and MAC LCD policies. Coverage varies by payer, so verify covered diagnoses against the applicable LCD before submitting.

Serum albumin thresholds that trigger coverage are not universal, because each MAC sets its own LCD criteria. Some LCDs require a documented serum albumin level below 2.0 g/dL or 2.5 g/dL before approving infusion. Include the relevant lab value in the clinical note and check it against the applicable LCD before billing. Confirm each description against our ICD-10-CM code library before the coder locks the claim.

Documentation requirements for medical necessity

Medical necessity documentation is the most common failure point in albumin infusion audits. Payers routinely request records to verify that the clinical criteria for P9046 were met before payment is finalized. Incomplete documentation leads to post-payment recoupment, which is harder to recover from than a pre-payment denial.

The chart should contain all of the following before a P9046 claim is submitted:

• Physician order: A signed order specifying albumin 25%, dose (in grams or ml), route, and frequency
• Diagnosis documentation: The clinical condition supporting use, with the ICD-10-CM code tied to the encounter note
• Lab values: Serum albumin level confirming hypoalbuminemia, with date and result (check your MAC LCD for the threshold that triggers coverage)
• Infusion record: Volume administered per session (ml), start and stop times, and any adverse reactions
• Prior authorization: Evidence of pre-authorization where the payer requires it. Commercial plans frequently do, while Medicare Part B generally does not for standard indications
• Medical necessity statement: A brief clinical narrative explaining why albumin 25% was selected over lower-concentration alternatives (particularly important for post-surgical or non-hepatic indications)

For practices with recurring albumin patients, build the intake and infusion record into an EMR template. Teams that capture this documentation at the point of care see fewer denials than those completing charts retrospectively.

P9045 vs P9046: Understanding the difference

The most frequent coding error in albumin billing is using P9045 and P9046 interchangeably. The two codes describe the same drug class at different concentrations, and that clinical decision matters to payers. Confirm the concentration documented in the order before the billing team selects the code.

When the clinical record shows a 25% solution was administered, P9046 is the correct code. Billing P9045 for a 25% infusion is an upcoding or downcoding error depending on volume. Either way it creates a compliance risk or a revenue loss. The order and the infusion record should specify the concentration explicitly.

Related HCPCS blood product codes

P9046 sits within a broader family of P-series blood and blood product codes. Coders working with albumin and plasma products regularly meet adjacent codes during crosswalk and crosscheck work. The table below covers the closest neighbors in the P9041-P9051 range for hospital outpatient and infusion billing teams.

Concentration alone does not settle the code, because package volume splits the albumin products across separate entries. When the product administered is albumin 25% in a 50 ml package, P9047 is the closer match than P9046. Verify the NDC-to-HCPCS mapping against the current CMS quarterly ASP pricing file to confirm which code fits the product dispensed. The four albumin codes sort cleanly on two axes, concentration and package volume.

Buy-and-bill vs. supplier billing for albumin infusion

How a practice acquires albumin 25% determines how it bills P9046 to Medicare. Two main pathways exist, and each has distinct compliance obligations.

Buy-and-bill pathway

Under buy-and-bill, the physician or facility purchases albumin 25% directly from a distributor and administers it to the patient. The practice then bills Medicare Part B for both the drug (P9046) and the administration service (a CPT infusion code). Medicare reimburses at ASP+6% for the drug component. The practice absorbs the acquisition cost and earns the spread between that cost and ASP+6%.

Buy-and-bill carries compliance risk. Acquiring and billing biologics under this model draws anti-kickback statute analysis, and inaccurate billing adds False Claims Act exposure. Review the arrangement with a healthcare attorney before launching a buy-and-bill albumin service. Documentation of acquisition cost, NDC, lot number, and expiration date strengthens the audit trail.

Supplier or hospital outpatient pathway

In the supplier pathway, a pharmacy or infusion center acquires and bills for the albumin product separately. The administering provider then bills only for the infusion service, using the CPT administration code. This splits the drug and administration billing between two entities and reduces the physician’s inventory and compliance burden. Hospital outpatient departments typically bill P9046 through the OPPS rather than the Part B drug schedule, which changes the payment rate and bundling rules.

How Pabau keeps P9046 units and documentation together

In most infusion practices the P9046 unit count is worked out twice. A nurse records the volume in the infusion note. Days later a biller reads that note, divides by 20, and types the result into the claim. Each handoff is a chance for the number to drift.

Pabau, our practice management software, keeps the infusion record and the charge on the same patient timeline. The volume the clinician documents is the volume the biller works from, and the supporting ICD-10 code stays attached to that encounter. The claim carries the same figure the chart does, with no re-key step in between.

That closes the three failure points this guide keeps returning to:

• The unit count comes from the documented volume, not from a second transcription
• The supporting diagnosis is prompted at charge capture, rather than chased after a denial
• Claim status is tracked through to remittance, so an underpayment on P9046 surfaces early

Bill albumin infusions right the first time

Pabau ties the infusion record, the supporting diagnosis, and the claim to one encounter. Your billers read the documented volume instead of retyping it.

Book a demo

Conclusion

HCPCS code P9046 is one of the few drug codes where the billing unit and the package size almost never match. Read the volume off the infusion record, divide by 20, and the code stops being difficult.

What is left is the part payers audit hardest: The clinical justification. A correct unit count on a chart with no serum albumin value and no signed order still fails on review. Decide now whether your infusion note captures that lab value, or accept that some P9046 claims will be recouped after payment.

Book a demo to see how Pabau keeps the infusion record, the diagnosis, and the claim on one encounter.

Continue your research

Need a structured billing framework for your infusion service? Understanding revenue cycle management covers the end-to-end process from charge capture to remittance reconciliation.

Managing denials after albumin infusion claims are rejected? Denial codes in medical billing explains the most common remittance advice codes and how to respond to each one.

Building documentation habits that survive an audit? Medical billing compliance covers the records payers ask for and the routines that keep them complete.

Frequently asked questions